William G. Kramer

Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure*

Dennis Vargo, William G. Kramer, Paula Black et al. · Clinical Pharmacology & Therapeutics · 1995 · 299 citations

Safety, Pharmacokinetics, and Effects on Cognitive Function of Multiple Doses of GTS-21 in Healthy, Male Volunteers

Harumi KITAGAWA, Toshiharu TAKENOUCHI, Ryotaro Azuma et al. · Neuropsychopharmacology · 2002 · 234 citations · Full text

Psychoactive Drug, Psychiatry, Cognitive Performance +9

Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study of ACE-011 (ActRIIA-IgG1) in Postmenopausal Women

Jon Ruckle, Mark Jacobs, William G. Kramer et al. · Journal of Bone and Mineral Research · 2008 · 207 citations

Sclerostin, Gynecology, Pharmacotherapy +17

Pharmacokinetics of Amphotericin B in Infants and Children

Jeffrey R. Starke, E. O. Mason, William G. Kramer et al. · The Journal of Infectious Diseases · 1987 · 126 citations

Drug Safety, Medicine, Bioanalysis +11

DEMOGRAPHIC FACTORS AFFECTING THE PHARMACOKINETICS OF CYCLOSPORINE ESTIMATED BY RADIOIMMUNOASSAY

Barry D. Kahan, William G. Kramer, C A Wideman et al. · Transplantation · 1986 · 126 citations

Therapeutic Drug Monitoring, Renal Function, Pharmacokinetic Modeling +13